Literature DB >> 32540516

Factors associated with state legislators' support for opioid use disorder parity laws.

Katherine L Nelson1, Jonathan Purtle2.   

Abstract

BACKGROUND: In the United States, state behavioral health parity laws play a crucial role in ensuring equitable insurance coverage and access to substance use disorder treatment and services for people that need them. State legislators have the exclusive authority to adopt these laws. The purpose of this study was to identify legislator beliefs independently associated with "strong support" for opioid use disorder (OUD) parity.
METHODS: Data were from a 2017 cross-sectional, state-stratified, multi-modal survey of state legislators (N = 475). The dependent variable was "strong support" for OUD parity. Primary independent variables were beliefs about state parity laws. Bivariate analyses and mixed effects logistic regression were conducted.
RESULTS: Legislators who "strongly supported" OUD parity were significantly more likely than legislators who did not "strongly support" OUD parity to be female (64.1% vs. 46.5%, p<.001) , Democrat (76.2% vs. 29.3%, p<.001), and have liberal, compared to conservative, ideology (85.6% vs. 27.1%, p<.001). After adjusting for legislator demographics and state-level covariates, beliefs such as agreeing that state parity laws do not increase health insurance premium costs (aOR=6.77, p<.01) and that substance use disorder treatments can be effective (aOR=5.00, p<.001) remained associated with "strong support" for OUD parity. These state legislators' beliefs were more strongly associated with "strong support" for OUD parity than political party, ideology, and other demographic and state-level characteristics.
CONCLUSIONS: Dissemination materials and communication strategies to cultivate support for OUD parity laws among state legislators should focus on the fiscal impacts of parity laws and the effectiveness of substance use disorder treatments.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavioral health parity laws; Opioid use disorder; State legislators

Mesh:

Year:  2020        PMID: 32540516      PMCID: PMC7483853          DOI: 10.1016/j.drugpo.2020.102792

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  52 in total

1.  Legislators' Perceptions and Knowledge of the Athletic Training Profession: Specific Considerations for Secondary Schools.

Authors:  Alicia M Pike Lacy; Christianne M Eason; Rebecca L Stearns; Sararat Tosakoon; Douglas J Casa
Journal:  J Athl Train       Date:  2019-09-25       Impact factor: 2.860

2.  How Narrative Focus and a Statistical Map Shape Health Policy Support Among State Legislators.

Authors:  Jeff Niederdeppe; Sungjong Roh; Caitlin Dreisbach
Journal:  Health Commun       Date:  2015-06-18

3.  Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications.

Authors:  Colleen M Grogan; Christina Andrews; Amanda Abraham; Keith Humphreys; Harold A Pollack; Bikki Tran Smith; Peter D Friedmann
Journal:  Health Aff (Millwood)       Date:  2016-12-01       Impact factor: 6.301

4.  Medicaid and Children's Health Insurance Programs; Mental Health Parity and Addiction Equity Act of 2008; the Application of Mental Health Parity Requirements to Coverage Offered by Medicaid Managed Care Organizations, the Children's Health Insurance Program (CHIP), and Alternative Benefit Plans. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-03-30

5.  The United States' Federal Parity Act and treatment of substance use disorders: Administrators' familiarity and perceptions of impact.

Authors:  Mary B Edmond; Lydia Aletraris; Paul M Roman; Dail L Fields; Brian E Bride
Journal:  Int J Drug Policy       Date:  2016-06-01

6.  State Legislators' Support for Behavioral Health Parity Laws: The Influence of Mutable and Fixed Factors at Multiple Levels.

Authors:  Jonathan Purtle; Félice Lê-Scherban; X I Wang; Paul T Shattuck; Enola K Proctor; Ross C Brownson
Journal:  Milbank Q       Date:  2019-11-11       Impact factor: 4.911

7.  Are Policy Strategies for Addressing the Opioid Epidemic Partisan? A View from the States.

Authors:  Colleen M Grogan; Clifford S Bersamira; Phillip M Singer; Bikki Tran Smith; Harold A Pollack; Christina M Andrews; Amanda J Abraham
Journal:  J Health Polit Policy Law       Date:  2020-04-01       Impact factor: 2.265

Review 8.  Communication Strategies to Counter Stigma and Improve Mental Illness and Substance Use Disorder Policy.

Authors:  Emma McGinty; Bernice Pescosolido; Alene Kennedy-Hendricks; Colleen L Barry
Journal:  Psychiatr Serv       Date:  2017-10-02       Impact factor: 3.084

9.  Effects of news media messages about mass shootings on attitudes toward persons with serious mental illness and public support for gun control policies.

Authors:  Emma E McGinty; Daniel W Webster; Colleen L Barry
Journal:  Am J Psychiatry       Date:  2013-05       Impact factor: 18.112

10.  Advancing a conceptual model of evidence-based practice implementation in public service sectors.

Authors:  Gregory A Aarons; Michael Hurlburt; Sarah McCue Horwitz
Journal:  Adm Policy Ment Health       Date:  2011-01
View more
  3 in total

1.  An Examination of Factors Affecting State Legislators' Support for Parity Laws for Different Mental Illnesses.

Authors:  Meagan Pilar; Jonathan Purtle; Byron J Powell; Stephanie Mazzucca; Amy A Eyler; Ross C Brownson
Journal:  Community Ment Health J       Date:  2022-06-11

2.  State Legislators' Divergent Social Media Response to the Opioid Epidemic from 2014 to 2019: Longitudinal Topic Modeling Analysis.

Authors:  Daniel C Stokes; Jonathan Purtle; Zachary F Meisel; Anish K Agarwal
Journal:  J Gen Intern Med       Date:  2021-03-29       Impact factor: 5.128

3.  Translating Medicaid policy into practice: policy implementation strategies from three US states' experiences enhancing substance use disorder treatment.

Authors:  Erika L Crable; Allyn Benintendi; David K Jones; Alexander Y Walley; Jacqueline Milton Hicks; Mari-Lynn Drainoni
Journal:  Implement Sci       Date:  2022-01-06       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.